Forum

Clinical Pharmacology & Therapeutics (2008) doi:10.1038/sj.clpt.6100328

Thorough QT Study With Recommended and Supratherapeutic Doses of Tolterodine

B Olshansky1 and DB Serra2

  1. 1Division of Cardiology, University of Iowa Hospitals, Iowa, USA
  2. 2Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA

Correspondence: BOlshansky, brianolshansky@msn.com

Extra navigation

.

naturejobs

More science jobs
Post a job for free
ADVERTISEMENT